Category archives for: Business

Sr. Vice President of Paychex Inc (NASDAQ:PAYX), Gioja Michael E, sells 35,293 shares worth $3,393,775

According to Paychex Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 03:56 PM, company Sr. Vice President, Gioja Michael E disclosed selling 35,293 shares at a cost of $96.16. At the time of this transaction (Apr 13), this trade was worth $3,393,775 in total. […]

Director of Amrep Corp. (NYSE:AXR), Cloues Edward B Ii, buys 1,500 shares worth $15,577

According to Amrep Corp.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:31 PM, company Director, Cloues Edward B Ii disclosed buying 1,500 shares at a cost of $10.38. At the time of this transaction (Apr 14), this trade was worth $15,577 in total. As […]

Sr. Vice President of Paychex Inc (NASDAQ:PAYX), Gioja Michael E, sells 35,294 shares worth $3,371,636

According to Paychex Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 03:56 PM, company Sr. Vice President, Gioja Michael E disclosed selling 35,294 shares at a cost of $95.53. At the time of this transaction (Apr 12), this trade was worth $3,371,636 in total. […]

10% Owner of Servicesource International, Inc. (NASDAQ:SREV), Edenbrook Capital, Llc, buys 27,226 shares worth $37,952

According to Servicesource International, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:31 PM, company 10% Owner, Edenbrook Capital, Llc disclosed buying 27,226 shares at a cost of $1.39. At the time of this transaction (Apr 14), this trade was worth $37,952 in total. […]

Portfolio Manager of Rivernorth/Doubleline Strategic Opportunity Fund, Inc. (NYSE:OPP), O’Neill Stephen Andrew, sells 20,064 shares worth $307,531

According to Rivernorth/Doubleline Strategic Opportunity Fund, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 03:16 PM, company Portfolio Manager, O’Neill Stephen Andrew disclosed selling 20,064 shares at a cost of $15.33. At the time of this transaction (Apr 12), this trade was worth $307,531 […]

10% Owner of Servicesource International, Inc. (NASDAQ:SREV), Edenbrook Capital, Llc, buys 18,504 shares worth $25,776

According to Servicesource International, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:31 PM, company 10% Owner, Edenbrook Capital, Llc disclosed buying 18,504 shares at a cost of $1.39. At the time of this transaction (Apr 13), this trade was worth $25,776 in total. […]

10% Owner of Levi Strauss & Co (NYSE:LEVI), Eisenhardt Elizabeth H, sells 146,788 shares worth $3,890,924

According to Levi Strauss & Co’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 02:12 PM, company 10% Owner, Eisenhardt Elizabeth H disclosed selling 146,788 shares at a cost of $26.51. At the time of this transaction (Apr 13), this trade was worth $3,890,924 in […]

10% Owner of Servicesource International, Inc. (NASDAQ:SREV), Edenbrook Capital, Llc, buys 25,000 shares worth $34,875

According to Servicesource International, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:31 PM, company 10% Owner, Edenbrook Capital, Llc disclosed buying 25,000 shares at a cost of $1.40. At the time of this transaction (Apr 12), this trade was worth $34,875 in total. […]

10% Owner of Levi Strauss & Co (NYSE:LEVI), Eisenhardt Elizabeth H, sells 175,526 shares worth $4,607,452

According to Levi Strauss & Co’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 02:12 PM, company 10% Owner, Eisenhardt Elizabeth H disclosed selling 175,526 shares at a cost of $26.25. At the time of this transaction (Apr 12), this trade was worth $4,607,452 in […]

Director of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Andersen Eric, buys 23,629 shares worth $143,194

According to Merrimack Pharmaceuticals Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Apr 14 04:05 PM, company Director, Andersen Eric disclosed buying 23,629 shares at a cost of $6.06. At the time of this transaction (Apr 12), this trade was worth $143,194 in total. As of […]

Featured Press Releases

Photo Gallery

Log in